Interact to see
Advertisement
Advertisement
CNPCX vs RNPAX
CNPCX vs RNPAX Comparison
Open Charts CNPCX vs RNPAX
CNPCX vs RNPAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CNPCX vs. RNPAX commentary
Jul 14, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPCX is a Hold and RNPAX is a Hold.
FUNDAMENTALS
Fundamentals
CNPCX (170B) and RNPAX (170B) have equal amount of cash in the bank . RNPAX pays higher dividends than CNPCX: RNPAX (0.37) vs CNPCX (0.30). CNPCX was incepted earlier than RNPAX: CNPCX (24 years) vs RNPAX (24 years). CNPCX (1.51) and RNPAX (1.49) have similar cost to investors . CNPCX (23.00) and RNPAX (23.00) have comparable annual turnover. CNPCX (250) and RNPAX (250) have matching initial minimum investment requirements. CNPCX (6.18) and RNPAX (6.13) have marching annual gain over last year. CNPCX (8.16) and RNPAX (8.01) have equivalent 5 years return.
| CNPCX | RNPAX | CNPCX / RNPAX | |
| Total Expense Ratio | 1.51 | 1.49 | 101% |
| Annual Report Gross Expense Ratio | 1.51 | 1.49 | 101% |
| Fund Existence | 24 years | 24 years | - |
| Gain YTD | 4.890 | 4.905 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 170B | 170B | 100% |
| Annual Yield % from dividends | 0.30 | 0.37 | 82% |
| Returns for 1 year | 6.18 | 6.13 | 101% |
| Returns for 3 years | 30.06 | 29.92 | 100% |
| Returns for 5 years | 8.16 | 8.01 | 102% |
| Returns for 10 years | 96.25 | 95.18 | 101% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PICEX | 6.86 | N/A | N/A |
| Virtus SGA Emerging Markets Equity C | |||
| SEEIX | 14.52 | N/A | N/A |
| SEI International Equity I (SIT) | |||
| FTDZX | 212.97 | N/A | N/A |
| Franklin Biotechnology Discovery Adv | |||
| TRSLX | 6.47 | N/A | N/A |
| Transamerica Small Cap Value R | |||
| DFCEX | 33.36 | -0.99 | -2.88% |
| DFA Emerging Markets Core Equity 2 I | |||